Age of tactical ideologues is over as Spain dominates new era of pragmatism | Jonathan Wilson
Trump asks US supreme court to pause ban-or-divest law for TikTok
Albania bans TikTok for a year after fatal stabbing of teenager last month
Trump nominates Miami-Dade official as Panama ambassador amid canal row
ECB faces tough task after flip in fortunes for eurozone economies
Market value drops by 6% on concerns that new lung cancer drug may not be as successful as hoped
Nearly £10bn has been wiped off the stock market value of AstraZeneca over concerns that a new lung cancer drug may not be as successful as had been hoped.
Shares in the Anglo-Swedish pharmaceutical company fell by as much as 6% on Monday morning after it published the first results from its phase 3 trial for datopotamab deruxtecan, making it the biggest faller among FTSE 100 companies.
More Stories
‘Godfather of AI’ shortens odds of the technology wiping out humanity over next 30 years
How owls helped me conquer my fear of the dark
‘All people could do was hope the nerds would fix it’: the global panic over the millennium bug, 25 years on